L. Nicod (Bern, Switzerland), S. Gaine (Dublin, Ireland)
Membrane diffusion and capillary blood volume in systemic sclerosis-associated pulmonary arterial hypertension (SScPAH) and systemic sclerosis (SSc) without PAH M. Overbeek, H. Groepenhoff, A. Voskuyl, A. Vonk Noordegraaf, E. Smit, B. Dijkmans, A. Boonstra (Amsterdam, Netherlands)
|  |
Survival and prognostic factors of acute exacerbations of pulmonary arterial hypertension B. Sztrymf, L. Bertoletti, A. M. Hamid, X. Jaïs, A. Yaïci, O. Sitbon, M. Humbert, G. Simonneau (Clamart, France)
|  |
Responsiveness of cambridge pulmonary hypertension outcome review (CAMPHOR) scores and utility in pulmonary hypertension (PH) patients S. McKenna, D. Meads, N. Doughty, J. Pepke-Zaba (Manchester, Cambridge, United Kingdom)
|  |
Real time biotelemetry applied to the six-minute walking test in patients with pulmonary hypertension S. Menna Barreto, M. Gazzana, D. Silva, M. Knorst, A. John, S. Canani, A. Muller, P. Sanches, D. Silva, A. Susin, P. Nohama, M. Moreira (Rio Grande do Sul, Brazil)
|   |
Non-invasive determination of cardiac output by the inertgas rebreathing method compared with magnetic resonance tomography J. Saur, T. Papavassiliu, F. Trinkmann, J. Weissmann, D. Dinter, M. Borggrefe, J. Kaden (Mannheim, Germany)
|  |
Prospective evaluation of pulmonary vascular involvement in patients with chronic myeloproliferative disorders C. Lamberto, J. J. Kiladjian, Y. Uzunhan, H. Nunes (Bobigny, France)
|   |
Reduced incremental shuttle walking test distance is associated with a worse survival in pulmonary arterial hypertension associated with systemic sclerosis C. A. Elliot, C. Billings, I. Armstrong, J. Waterhouse, C. Billings, M. Akil, D. G. Kiely (Sheffield, United Kingdom)
|  |
Pulmonary arterial hypertension (PAH) in primary Sjögren‘s syndrome: report of 9 cases D. Launay, X. Jaïs, A. Yaïci, E. Hachulla, P. Y. Hatron, O. Sitbon, G. Simonneau, M. Humbert (Clamart, Lille, France)
|  |
Peripheral endothelial dysfunction in patients with pulmonary artery hypertension N. Peled, D. Bendayan, D. Shitrit, B. Fox, M. Kramer (Petach Tiqwa, Israel)
|  |
Gas transfer relates to pulmonary haemodynamics and survival in pulmonary arterial hypertension associated with systemic sclerosis C. Billings, C. A. Elliot, I. Armstrong, L. Smith, M. Akil, D. G. Kiely (Sheffield, United Kingdom)
|  |
Right-to-left shunt in pulmonary hypertension J. F. Vodoz, V. Cottin, J. Y. Bayle, G. Derumeaux, J. F. Cordier (Lyon (Bron), France)
|  |
Management of PAH associated with systemic lupus erythematosus (SLE) or mixed connective tissue disease (MCTD): immunosuppressive therapy (IT) alone or combined with PAH specific therapies? X. Jais, D. Launay, A. Yaici, O. Sitbon, J. Le Pavec, B. Sztrymf, C. Tcherakian, A. M. Hamid, L. Achouh, F. Parent, G. Simonneau, M. Humbert (Clamart, Lille, France)
|  |
Nocturnal and diurnal oxygen desaturations in patients with chronic pulmonary embolism D. Drozdz, J. Lewczuk, P. Piszko, L. Lenartowska, J. Jagas, A. Drozdz (Wroclaw, Poland)
|  |
Successful conversion of patients using nebulised iloprost from multisonic nebuliser to adaptive aerosol delivery nebuliser J. Wilkinson, L. Martin, P. Sephton, N. Hamilton, I. Armstrong, C. A. Elliot, D. G. Kiely (Sheffield, United Kingdom)
|  |
Pulmonary arterial hypertension (PAH) among end state renal disease (ESRD) patients under chronic hemodyalisis (HD) P. Rioseco, M. Rubilar, F. Verbal, C. Pedreros, R. Lopez (Talcahuano, Chile)
|  |
Prevalence of pulmonary arterial hypertension using doppler echocardiografic method in sickle cell disease S. Menna Barreto, M. Gazzana, A. John, S. Canani, F. Svartman, D. Silva, R. Albanese, C. Bittar (Porto Alegre, Rio Grande do Sul, Brazil)
|   |
Pulmonary hypertension (PH) in end-stage renal (ESRD) patients receiving dialysis: prevalence and clinical significance K. Ramasubbu, Z. Safdar, A. Frost (Houston, TX, United States Of America)
|  |
Interleukin-13-dependent regulation of endothelin-1 expression in pulmonary arterial hypertension M. Hecker, A. Zakrzewicz, M. George, W. Seeger, H. Ghofrani, O. Eickelberg (Giessen, Germany)
|   |
Morphological and molecular alterations of pulmonary vasculature in a pig model with increased pulmonary blood flow and pressure compared to "pulmonary plexogenic arteriopathy" (PPA) in children E. Herpel, P. A. Schnabel, H. Klimpel, S. Hagl, M. M. Gebhard, M. Gorenflo (Heidelberg, Germany; Heidelberg, Greece)
|   |
Pulmonary thromboendarterectomy in chronic thromboembolic pulmonary hypertension: initial experience of Hospital de Clínicas de Porto Alegre S. Menna Barreto, M. Gazzana, A. John, S. Canani, L. F. Araujo, M. Saueressig, A. Moreschi, H. Oliveira, A. Macedo Neto (Porto Alegre, Rio Grande do Sul, Brazil)
|   |